Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Pharmaceutical Manufacturing
Parkville, Victoria-based Pio Therapeutics Pty Ltd operates in Pharmaceutical Manufacturing. It is privately held, and its site is piotx.com. It holds one address on record, all in Australia. It self-reports a headcount band of 2–10. One Australian registration (ABN) is a confirmed match. It is listed alongside six similar brands, mostly in Biotechnology Research.
ABN12650004505
| PIO THERAPEUTICS PTY LTD | ABN 12650004505 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Our mission is to develop novel, innovative and targeted medicines that augment endogenous anti-tumour immunity to further improve outcomes for patients affected by cancer.
When harnessed appropriately, the immune system is an extremely potent and specific endogenous anti-tumour mechanism. Our first-in-class agonist antibody has been designed to address current clinical challenges associated with immunotherapy such as improving the rate and quality of responses, while also addressing the clinical challenges that have been encountered with recombinant IL-21.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
One Victoria entity on the ABR: PIO THERAPEUTICS PTY LTD (ABN 12 650 004 505), high confidence.
One address on record, Australia only. Primary: 407 Royal Pde, Parkville, Victoria 3052.
None linked to this brand.
1 profile lists Pio Therapeutics Pty Ltd as a peer — 46th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. BioPacific Partners lists it back.